Physician profile
Jonathan M Archer
NPI 1205879525
$6,750.77
in general payments reported to CMS, 2019-2025
22 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $1,006 · 2021: $386 · 2022: $1,871 · 2023: $2,794 · 2024: $64.34 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,020 · Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,020.12 |
| Food and Beverage | $1,129.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,443.87 | 2019-2025 | Journey, Ri Hip Navigation, Or3o Dual Mobility |
| Seapearl East, INC | $2,132.10 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $610.43 | 2019-2023 | Stratum Foot Plating System, Quattro |
| Kowa Pharmaceuticals America, INC. | $296.75 | 2022-2023 | Seglentis |
| Depuy Synthes Sales INC. | $237.06 | 2019-2025 | Monovisc, Orthovisc |
| Heron Therapeutics, INC. | $213.18 | 2021-2025 | Zynrelef |
| Horizon Therapeutics Plc | $188.78 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $114.74 | 2019-2022 | |
| Globus Medical, INC. | $85.17 | 2023-2025 | Proximal Humerus Strut, Actify 3d |
| Convatec INC. | $78.80 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $72.44 | 2019-2024 | Euflexxa |
| Orthosensor INC. | $40.00 | 2020 | |
| Fidia Pharma USA INC. | $32.48 | 2019-2021 | |
| Heraeus Medical, LLC. | $31.61 | 2022 | |
| Bioventus LLC | $31.27 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $30.13 | 2023-2024 | Iovera, Zilretta, Exparel |
| Medacta USA, INC. | $23.66 | 2025 | Spherika |
| Linkbio Corp | $23.42 | 2025 | |
| Intellijoint Surgical INC. | $20.86 | 2019 | |
| Molnlycke Health Care US, LLC | $16.88 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.42 | 2025 | Relistor |
| Pacira Therapeutics, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.